99 related articles for article (PubMed ID: 872312)
21. Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label.
Ord JM; Hasapes J; Daugherty A; Thorpe SR; Bergmann SR; Sobel BE
Circulation; 1992 Jan; 85(1):288-97. PubMed ID: 1728459
[TBL] [Abstract][Full Text] [Related]
22. Behaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis.
Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
Gut; 1977 Jul; 18(7):547-55. PubMed ID: 873336
[TBL] [Abstract][Full Text] [Related]
23. Acute phase reaction, fibrinogen level and thrombus size.
Chooi CC; Gallus AS
Thromb Res; 1989 Mar; 53(5):493-501. PubMed ID: 2499942
[TBL] [Abstract][Full Text] [Related]
24. Anti D dimer monoclonal antibodies: a possible scintigraphic agent for immunodetection of thrombi.
Scopinaro F; Di Loreto M; Banci M; Schillaci O; Di Macio L; de Santis R; Anastasi AM; Ciancarella W; Centi Colella A; Mele A
Nucl Med Commun; 1992 Oct; 13(10):723-9. PubMed ID: 1491836
[TBL] [Abstract][Full Text] [Related]
25. Highly iodinated fibrinogen: a new thrombus-localizing agent.
Harwig JF; Coleman RE; Harwig SS; Sherman LA; Siegel BA; Welch MJ
J Nucl Med; 1975 Aug; 16(8):756-63. PubMed ID: 240916
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
Cercek B; Lew AS; Hod H; Yano J; Reddy NK; Ganz W
Circulation; 1986 Sep; 74(3):583-7. PubMed ID: 3091287
[TBL] [Abstract][Full Text] [Related]
27. In vitro stability and in vivo clearance of fibrinogen or serum albumin labeled with 77Br, 131I, or 125I by direct or indirect synthetic methods.
Knight LC; Harwig SL; Welch MJ
J Nucl Med; 1977 Mar; 18(3):282-8. PubMed ID: 839278
[TBL] [Abstract][Full Text] [Related]
28. Catabolism of rabbit prothrombin in rabbits: uptake of prothrombin by the aorta wall before and after a de-endothelializing injury in vivo.
Hatton MW; Southward SM; Serebrin SD; Kulczycky M; Blajchman MA
J Lab Clin Med; 1995 Dec; 126(6):521-9. PubMed ID: 7490511
[TBL] [Abstract][Full Text] [Related]
29. Attempted diagnosis of ventricular mural thrombi in acute mycardial infarction using 125I-labelled fibrinogen.
Erhardt LR; Sjögren A
Acta Med Scand; 1976; 200(1-2):127-130. PubMed ID: 961466
[TBL] [Abstract][Full Text] [Related]
30. Thrombus imaging in dogs with a monoclonal antibody (SZ-51) specific for activated human platelets.
Wu GX; He GR; Wu JC; Ruan CG
Chin Med J (Engl); 1992 Jul; 105(7):553-9. PubMed ID: 1280552
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoimaging of venous thrombi using iodine-131 monoclonal antibody.
Rosebrough SF; Kudryk B; Grossman ZD; McAfee JG; Subramanian G; Ritter-Hrncirik CA; Witanowski LS; Tillapaugh-Fay G
Radiology; 1985 Aug; 156(2):515-7. PubMed ID: 4011916
[TBL] [Abstract][Full Text] [Related]
32. A method for generating obstructive thrombi in the coronary arteries of the conscious dog.
Hayashi I; Wasfie T; Freed P; Ekstrom M; Polanski J; Yoshizu H; Stein P; Kantrowitz A
Cardiovasc Res; 1983 May; 17(5):294-300. PubMed ID: 6883406
[TBL] [Abstract][Full Text] [Related]
33. Clearance characteristics of des-AA fibrin and des-AABB fibrin, and thrombus-related uptake of des-AABB fibrin as compared to fibrinogen.
Nilsen DW; Brosstad F; Holm B; Kierulf P; Godal HC
Scand J Clin Lab Invest Suppl; 1985; 178():115-9. PubMed ID: 3867112
[TBL] [Abstract][Full Text] [Related]
34. Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats.
Cardona-Sanclemente LE; Born GV
Br J Pharmacol; 1996 Mar; 117(6):1089-94. PubMed ID: 8882601
[TBL] [Abstract][Full Text] [Related]
35. Uptake of 125I-Lys-plasminogen by in vitro thrombi.
Iga Y; Greenwald SR; Chandler AB
Haemostasis; 1983; 13(1):25-35. PubMed ID: 6840626
[TBL] [Abstract][Full Text] [Related]
36. 111In-labeled platelet scintigraphy and two-dimensional echocardiography for detection of left atrial appendage thrombi. Studies in a new canine model.
Vandenberg BF; Seabold JE; Conrad GR; Kieso R; Johnson J; Fox-Eastham K; Ponto J; Bruch P; Kerber RE
Circulation; 1988 Oct; 78(4):1040-6. PubMed ID: 3168184
[TBL] [Abstract][Full Text] [Related]
37. The effect of dextran on the lysability of ex vivo thrombi.
Aberg M; Bergentz SE; Hedner U
Ann Surg; 1975 Mar; 181(3):342-5. PubMed ID: 1130851
[TBL] [Abstract][Full Text] [Related]
38. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
[TBL] [Abstract][Full Text] [Related]
39. Molecular exchange between blood and in vitro thrombi.
Iga Y; Stella SR; Chandler AB
Haemostasis; 1984; 14(4):361-6. PubMed ID: 6500385
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen clearance from alveoli.
Meyer EC; Ottaviano R; Higgins JJ
J Appl Physiol Respir Environ Exerc Physiol; 1978 Oct; 45(4):516-20. PubMed ID: 711566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
